Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer

Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer

US Patent 7678372 · Granted Mar 16, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human anti-FGFR4 antibody2019
Method for treatment of diabetes by a small molecule inhibitor for GRK52016
FGFR4 antibodies2016
Quinoline derivatives as AXL kinase inhibitors2015
Quinoline derivatives as AXL kinase inhibitors2015
Inhibitors of her3 activity2015
Pharmaceutically active compounds as Axl inhibitors2015
Quinolinyloxyphenylsulfonamides2014
Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal tra2013
Human nerve growth factor by recombinant technology2013
FGFR4 antibodies2013
Diagnosis and prevention of cancer cell invasion2012